Francisco (UCSF) criteria are used to select patients with hepatocellular carcinoma (HCC) for liver transplantation (LT). Recurrent HCC is a significant cause of death. There is no widely accepted pathological assessment strategy to predict recurrent HCC after transplantation. This study compares th
A comparative study of pathological staging systems in predicting recurrent hepatocellular carcinoma after liver transplantation
โ Scribed by Okuno, Tomoko ;Tsuruyama, Tatsuaki ;Haga, Hironori ;Ueda, Mikiko ;Takada, Yasutsugu ;Maetani, Yoji ;Manabe, Toshiaki ;Tamaki, Keiji
- Book ID
- 113046896
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 207 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Orthotopic liver transplantation (OLTx) in the presence of hepatocellular carcinoma (HCC) has been complicated by high recurrence rates. The ability to determine the risk and timing of HCC recurrence on an individual basis would greatly aid in the candidate selection process resulting in a more effi
Cumulative recurrence after surgical resection for hepatocellular carcinoma (HCC) is very high. Several retrospective analyses have shown that liver transplantation was more effective than resection for patients with HCC at early tumor stages. Consequently, in January 1990, we decided to prospective